Valid for Submission
C94.32 is a billable diagnosis code used to specify a medical diagnosis of mast cell leukemia, in relapse. The code C94.32 is valid during the fiscal year 2021 from October 01, 2020 through September 30, 2021 for the submission of HIPAA-covered transactions.
Diagnostic Related Groups - MS-DRG Mapping
Convert C94.32 to ICD-9 Code
The General Equivalency Mapping (GEM) crosswalk indicates an approximate mapping between the ICD-10 code C94.32 its ICD-9 equivalent. The approximate mapping means there is not an exact match between the ICD-10 code and the ICD-9 code and the mapped code is not a precise representation of the original code.
Information for Patients
Leukemia is cancer of the white blood cells. White blood cells help your body fight infection. Your blood cells form in your bone marrow. In leukemia, the bone marrow produces abnormal white blood cells. These cells crowd out the healthy blood cells, making it hard for blood to do its work.
There are different types of leukemia, including
- Acute lymphocytic leukemia
- Acute myeloid leukemia
- Chronic lymphocytic leukemia
- Chronic myeloid leukemia
Leukemia can develop quickly or slowly. Chronic leukemia grows slowly. In acute leukemia, the cells are very abnormal and their number increases rapidly. Adults can get either type; children with leukemia most often have an acute type.Some leukemias can often be cured. Other types are hard to cure, but you can often control them. Treatments may include chemotherapy, radiation and stem cell transplantation. Even if symptoms disappear, you might need therapy to prevent a relapse.
NIH: National Cancer Institute
- B-cell leukemia/lymphoma panel (Medical Encyclopedia)
- Bone marrow transplant (Medical Encyclopedia)
- Hairy cell leukemia (Medical Encyclopedia)
- Leukemia (Medical Encyclopedia)
[Learn More in MedlinePlus]